MedPath

The prospective study of halitosis improvement by eradicating Helicobacter pylori.

Not Applicable
Conditions
Gstric infection of Helicobacter pylori
Registration Number
JPRN-UMIN000016378
Lead Sponsor
Kudo clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

2-1. Cases who had presented allergies to drugs contained in the eradication agent 2-2. Patients with a history of upper gastrointestinal tract surgery and pancreatoduodenectomy 2-3. Patients with malignancy detected by upper endoscopy or another test 2-4. Patients requiring upper emergency endoscopy 2-5. Patients with serious underlying disease (respiratory, cardiovascular, or endocrine disease) 2-6. Patients undergoing dialysis 2-7. Patients who were deemed ineligible for this trial by the principal investigator or co-investigators

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath